Space stocks crumble as SpaceX goes live at $150 per share

Space stocks crumble as SpaceX goes live at $150 per share
Wajeeh Khan
12 Jun 2026, 18:47 PM

powered by

Invezz
Buy EchoStar (SATS)

SATS is being sold for the wrong reason: it’s a connectivity/communications play that can benefit from the same capital cycle as Starlink-style demand, but it’s not a direct “SpaceX proxy.” If the selloff is mostly rotation-driven, SATS can rebound as investors realize it’s not competing for the same investor attention as launch/tourism names.

Key Risk: SATS fundamentals deteriorate (customer churn, pricing pressure, or funding/contract delays) so the rotation bounce can’t stick.

Sell Rocket Lab (RKLB)

SpaceX going live makes RKLB’s “mini-SpaceX” premium unwind fast. Investors rotate from proxies to the original, and RKLB’s valuation already looks stretched versus fundamentals. Expect continued multiple compression until Neutron delivers tangible milestones that re-earn a standalone story.

Key Risk: Neutron slips less than expected and delivers a clear, near-term revenue/launch cadence that forces the market to re-rate RKLB upward.

  • SpaceX debuted on Nasdaq this morning at $150 per share.
  • The listing is resulting in immense pressure on other space stocks.
  • Here's why SpaceX is triggering a sell off in RKLB, ASTS, LUNR, and SPCE.

SpaceX (SPCX)—billionaire Elon Musk’s artificial intelligence (AI) and space infrastructure firm—went live on Nasdaq today, opening at a whopping $150 per share.

This represents an 11% upside on the IPO price, which makes the giant worth just under $2 trillion.

But the historic listing brings an immediate, painful side effect for the broader space industry.

Peers Rocket Lab RKLB, Virgin Galactic (SPCE), Intuitive Machines Inc (LUNR), and EchoStar (SATS) all opened deep in the red today, giving back much of their recent gains.  

Here’s why space stocks are under pressure

For months, investors who wanted exposure to the commercial space economy had no choice but to buy proxies—RKLB as the “mini-SpaceX,” SATS as a direct ownership play, SPCE as a pure-play space tourism bet.

That dynamic evaporated the moment SpaceX stock started flashing across trading terminals.

Fund managers and retail traders moved to sell peers’ shares to free up cash for the massive offering.

SpaceX sold over 555 million shares in a deal that amounts to a $75 billion fundraise—comfortably the largest IPO in market history, surpassing Saudi Aramco’s 2019 record.

With that kind of capital call hitting the market, portfolio rebalancing was inevitable.

Why hold a proxy when you can own the original? The rotation trade is textbook: anticipation lifts the entire sector, execution drains it.

Rocket Lab stock, for example, was up 100% year-to-date in late May, purely on SPCX momentum – and now that the real thing is coming live itself, that premium is unwinding fast.

Why Virgin Galactic stock crashed the hardest

Virgin Galactic stock is being hit the hardest this morning as investors stare at the raw fundamentals.

The company generated just $227,000 in total revenue last quarter while posting a net loss of $64.7 million.

It guided Q2 free cash flow to a negative $87 million, with gradual improvement expected each quarter through 2026.

Management has reaffirmed Delta-class test flights in Q3 2026 and a first commercial spaceflight in Q4 2026, but those are still promises—not revenue.

With SpaceX now trading publicly, boasting roughly 12 million Starlink paid subscriptions against Virgin Galactic’s hundreds of unflown $450,000 ticket reservations, the contrast in scale is really impossible to ignore.

What happens next: the post-IPO hangover

The selloff in space proxies today is likely the first chapter of a longer recalibration, not a one-day event.

SpaceX’s valuation has raised concerns among some investors, and market jitters surrounding the IPO were already weighing on peers ahead of today's debut.

Now that SPCX stock is live, speculative premiums baked into names like Rocket Lab and EchoStar must compete directly against the real thing—and SpaceX’s pitch is formidable.

Its IPO filing claims a total addressable market of $28.5 trillion, with a significant portion tied to AI enterprise applications via its Starlink connectivity infrastructure.

Meanwhile, at a $2 trillion valuation, SpaceX would trade at a price-to-sales ratio of about 104x—steep, but still below Rocket Lab’s 123x and AST SpaceMobile’s 409x, which raises a question for investors: if SpaceX is a better business at a lower multiple, what exactly are you paying for in the proxies?

In short, the sector will need fresh operational catalysts—Rocket Lab’s Neutron launch and SPCE’s first commercial flight—to rebuild its identity outside the SpaceX shadow.